Amgen, Inc. (AMGN) Misses Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $382.47 -2.25%
EPS Growth %: +2.7%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +2.7%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amgen, Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.87, $0.07 worse than the analyst estimate of $1.94. Revenue for the quarter came in at $4.52 billion versus the consensus estimate of $4.76 billion.
For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Wynn Resorts prices $900M senior notes offering at 6.875%
- RUM Group to raise Northern Data stake to ~98% via share purchase
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
